Detalhe da pesquisa
1.
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
Kidney Int
; 104(2): 334-342, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736536
2.
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Am J Kidney Dis
; 81(5): 517-527.e1, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535535
3.
Utilization of Cystatin C in the Outpatient Setting.
Am J Nephrol
; 53(7): 534-541, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738242
4.
Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice.
J Ren Nutr
; 32(1): 51-57, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34429244
5.
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.
J Am Soc Nephrol
; 32(7): 1801-1812, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888577
6.
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Am J Nephrol
; 52(3): 180-189, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789284
7.
Sorting nexin 1 loss results in increased oxidative stress and hypertension.
FASEB J
; 34(6): 7941-7957, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293069
8.
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol
; 31(7): 1640-1651, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32487558
9.
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
Kidney Int
; 97(2): 370-382, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874800
10.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
N Engl J Med
; 377(20): 1930-1942, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29105594
11.
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
Am J Kidney Dis
; 76(2): 213-223, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32171640
12.
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
Kidney Int
; 96(1): 159-169, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30898339
13.
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
Kidney Int
; 95(5): 1253-1261, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922668
14.
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.
Pharmacogenet Genomics
; 29(1): 18-22, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30489456
15.
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Am J Hum Genet
; 98(6): 1193-1207, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259053
16.
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
J Am Soc Nephrol
; 29(10): 2458-2470, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228150
17.
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol
; 29(2): 571-578, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29118087
18.
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Kidney Int
; 93(3): 691-699, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290310
19.
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide.
Pharmacogenet Genomics
; 28(11): 251-255, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289819
20.
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
Am J Kidney Dis
; 71(2): 225-235, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150246